IN2015DN01616A - - Google Patents

Download PDF

Info

Publication number
IN2015DN01616A
IN2015DN01616A IN1616DEN2015A IN2015DN01616A IN 2015DN01616 A IN2015DN01616 A IN 2015DN01616A IN 1616DEN2015 A IN1616DEN2015 A IN 1616DEN2015A IN 2015DN01616 A IN2015DN01616 A IN 2015DN01616A
Authority
IN
India
Prior art keywords
tissue
cells
cell formulation
myocardial
pluripotent stem
Prior art date
Application number
Other languages
English (en)
Inventor
Masanori Yoshida
Shinya Minatoguchi
Mari Dezawa
Original Assignee
Clio Inc
Univ Gifu
Univ Tohoku
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Clio Inc, Univ Gifu, Univ Tohoku filed Critical Clio Inc
Publication of IN2015DN01616A publication Critical patent/IN2015DN01616A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0607—Non-embryonic pluripotent stem cells, e.g. MASC
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/03—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from non-embryonic pluripotent stem cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
IN1616DEN2015 2012-08-17 2013-08-15 IN2015DN01616A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2012181029 2012-08-17
PCT/JP2013/054049 WO2014027474A1 (ja) 2012-08-17 2013-02-19 心筋梗塞の修復再生を誘導する多能性幹細胞
PCT/JP2013/071981 WO2014027684A1 (ja) 2012-08-17 2013-08-15 心筋梗塞の修復再生を誘導する多能性幹細胞

Publications (1)

Publication Number Publication Date
IN2015DN01616A true IN2015DN01616A (es) 2015-07-03

Family

ID=50685515

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1616DEN2015 IN2015DN01616A (es) 2012-08-17 2013-08-15

Country Status (14)

Country Link
US (3) US9844570B2 (es)
EP (2) EP3659612B1 (es)
JP (1) JP5968442B2 (es)
KR (1) KR101730052B1 (es)
CN (1) CN104582711B (es)
AU (1) AU2013303492B2 (es)
CA (1) CA2882239C (es)
DK (1) DK2886123T3 (es)
ES (1) ES2767182T3 (es)
IN (1) IN2015DN01616A (es)
PL (1) PL2886123T3 (es)
PT (1) PT2886123T (es)
SG (2) SG11201501185WA (es)
WO (2) WO2014027474A1 (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014027474A1 (ja) 2012-08-17 2014-02-20 株式会社Ｃｌｉｏ 心筋梗塞の修復再生を誘導する多能性幹細胞
JP2015160820A (ja) * 2014-02-26 2015-09-07 株式会社Ｃｌｉｏ 慢性腎障害治療のための多能性幹細胞
JP6452107B2 (ja) 2014-09-05 2019-01-16 国立大学法人 東京大学 糖尿病性皮膚潰瘍治療のための多能性幹細胞
WO2016168993A1 (en) 2015-04-22 2016-10-27 Innolife Co., Ltd. Methods of tissue repair and regeneration
JP6770673B2 (ja) * 2016-02-26 2020-10-21 国立大学法人東海国立大学機構 急性心筋梗塞の予後マーカー及びその利用
SG11201811806TA (en) * 2016-07-01 2019-02-27 Univ Tohoku Prophylactic or therapeutic agent for organ fibrosis
WO2018021515A1 (ja) * 2016-07-29 2018-02-01 国立大学法人東北大学 血管障害の予防又は治療剤
EP3495471A4 (en) 2016-08-03 2020-02-19 Life Science Institute, Inc. METHOD FOR INDUCING THE DIFFERENTIATION OF PLURIPOTENT STEM CELLS IN VITRO
CA3032925A1 (en) * 2016-08-03 2018-02-08 Life Science Institute, Inc. Alleviation and treatment of ischemia reperfusion-induced lung injury using pluripotent stem cells
EP3494978A4 (en) * 2016-08-03 2020-03-11 National University Corporation Nagoya University IMPROVEMENT AND TREATMENT OF CHRONIC PULMONARY DISEASES USING PLURIPOTENT STEM CELLS
CN106822899B (zh) * 2017-03-10 2020-11-27 北京大学 一种通过抑制自噬促进心肌再生的药物
AU2018352904A1 (en) * 2017-10-17 2020-05-21 Hiroshima University Pluripotent stem cells inducing osteochondral repair
JP7102666B2 (ja) * 2018-01-25 2022-07-20 国立大学法人東海国立大学機構 Ｍｕｓｅ細胞動員剤及び心筋障害への利用
JP7072777B2 (ja) * 2018-07-03 2022-05-23 株式会社生命科学インスティテュート 慢性腎障害治療のための多能性幹細胞
CN110302212A (zh) * 2019-07-17 2019-10-08 陶正博 一种用于治疗急性心肌梗死的细胞制剂及其制备方法
US20220218744A1 (en) 2019-08-19 2022-07-14 Cellaxia Inc. Cell-containing pharmaceutical composition
US20220323509A1 (en) * 2019-09-05 2022-10-13 Tohoku University Therapeutic agent for myocarditis
CA3156700A1 (en) * 2019-10-31 2021-05-06 Life Science Institute, Inc. Therapy for interstitial cystitis by pluripotent stem cells
US20230203436A1 (en) 2020-04-02 2023-06-29 Tohoku University High-potential pluripotent stem cells
JP2021073305A (ja) * 2021-02-09 2021-05-13 株式会社生命科学インスティテュート 慢性腎障害治療のための多能性幹細胞

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994000484A1 (en) * 1992-06-22 1994-01-06 Young Henry E Scar inhibitory factor and use thereof
AU8401498A (en) * 1997-07-14 1999-02-10 Osiris Therapeutics, Inc. Cardiac muscle regeneration using mesenchymal stem cells
BR9912662A (pt) * 1998-07-31 2001-06-05 Genzyme Corp Melhoria de função cardìaca por transplante de célula de ramo mesenquimal
US20020061587A1 (en) 2000-07-31 2002-05-23 Piero Anversa Methods and compositions for the repair and/or regeneration of damaged myocardium
WO2002057430A2 (en) * 2001-01-20 2002-07-25 Cardion Ag Pluripotent adult stem cells derived from regenerative tissue
AU2002313670C1 (en) 2001-07-12 2009-08-06 Asterias Biotherapeutics, Inc. Cells of the cardiomyocyte lineage produced from human pluripotent stem cells
US9782439B2 (en) 2005-01-27 2017-10-10 Japan Health Sciences Foundation Cell sheet containing mesenchymal stem cells
EP2208786B1 (en) 2005-12-13 2018-08-01 Kyoto University Nuclear reprogramming factor
CN101517069A (zh) * 2006-07-13 2009-08-26 塞拉帝思股份公司 由人类胚泡来源的干细胞衍生的多能心脏前体细胞新种群
WO2009046058A1 (en) 2007-10-01 2009-04-09 University Of Miami A method to amplify cardiac stem cells in vitro and in vivo
JP5394932B2 (ja) 2007-11-02 2014-01-22 日本ケミカルリサーチ株式会社 ヒト間葉系幹細胞含有医薬組成物
JP5564679B2 (ja) * 2009-04-16 2014-07-30 公益財団法人ヒューマンサイエンス振興財団 心筋細胞分化誘導促進剤およびその使用方法
US9550975B2 (en) * 2009-07-15 2017-01-24 Mari Dezawa SSEA-3 pluripotent stem cell isolated from body tissue
EP2630234B1 (en) * 2010-10-18 2017-12-13 Sunshine Biotech Inc. Human multipotent embryonic stem cell-like progenitor cells
WO2014027474A1 (ja) 2012-08-17 2014-02-20 株式会社Ｃｌｉｏ 心筋梗塞の修復再生を誘導する多能性幹細胞

Also Published As

Publication number Publication date
CN104582711B (zh) 2019-12-06
AU2013303492B2 (en) 2017-02-16
US9844570B2 (en) 2017-12-19
CA2882239C (en) 2018-05-22
EP2886123B1 (en) 2019-10-23
KR101730052B1 (ko) 2017-04-25
US20180050067A1 (en) 2018-02-22
SG11201501185WA (en) 2015-05-28
PT2886123T (pt) 2020-01-22
EP3659612B1 (en) 2023-06-07
KR20150043482A (ko) 2015-04-22
CA2882239A1 (en) 2014-02-20
DK2886123T3 (da) 2020-01-27
WO2014027474A1 (ja) 2014-02-20
SG10201800829XA (en) 2018-03-28
US20190307806A1 (en) 2019-10-10
EP2886123A1 (en) 2015-06-24
EP2886123A4 (en) 2016-06-22
AU2013303492A1 (en) 2015-03-12
EP3659612A1 (en) 2020-06-03
US10639335B2 (en) 2020-05-05
JPWO2014027684A1 (ja) 2016-07-28
CN104582711A (zh) 2015-04-29
PL2886123T3 (pl) 2020-05-18
ES2767182T3 (es) 2020-06-16
US20150196600A1 (en) 2015-07-16
US10376544B2 (en) 2019-08-13
JP5968442B2 (ja) 2016-08-10
WO2014027684A1 (ja) 2014-02-20

Similar Documents

Publication Publication Date Title
IN2015DN01616A (es)
NZ623454A (en) Pharmaceutical composition for the treatment of heart diseases
MX2016005574A (es) Composiciones de ribosido de nicotinamida para uso topico en el tratamiento de afecciones de la piel.
BR112014010776A8 (pt) neurônios dopaminérgicos (da) mesencefálicos para enxerto
AU2009240884A8 (en) Agent for recruitment of bone-marrow-derived pluripotent stem cell into peripheral circulation
MX340276B (es) Metodos, sistema y aparato para la deteccion, diagnostico y tratamiento de trastornos del ritmo biologico.
ES2721180T3 (es) Productos terapéuticos usando células adiposas y secreciones celulares
MX340185B (es) Células precursoras cd27 1 derivadas de médula ósea para reparación cardíaca.
ES2572211T3 (es) Regeneración de músculo esquelético utilizando células madre mesenquimales
WO2012106367A3 (en) Pluripotent stem cells and method of stimulating and extracting non-embryonic pluripotent stem cells from mammal blood and using reconstituted pluripotent stem cells to treat diseases including chronic obstructive pulmonary disease
JP2014509319A5 (es)
WO2014183033A3 (en) G-csf for use in treating or preventing a disease associated with aging in a patient, for administration with a stem-cell containing composition and/or an electromagnetic signal
EA201490995A1 (ru) Использование фо-ти для усиления мобилизации и пролиферации стволовых клеток
SG11201900986YA (en) Alleviation and treatment of ischemia reperfusion-induced lung injury using pluripotent stem cells
CA2904533C (en) Enhanced osteogenic activity of daidzein analogs on human mesenchymal stem cells
Gui-xian et al. Therapeutic effects of umbilical cord mesenchymal stem cells transplantation on systemic lupus erythematosus
WO2014072720A3 (en) Cell differentiation
SG11201810188VA (en) Amelioration and treatment of perinatal brain damage with pluripotent stem cells
SG11201900983TA (en) Amelioration and treatment of chronic lung disease using pluripotent stem cells
WO2012169897A8 (en) Weight reducing material
WO2014063035A3 (en) Treatment of pain using amnion derived adherent cells
UA100881U (uk) Засіб для відновлення уражених тканин організму людини
PL418104A1 (pl) Sposób odnowy tkankowej z wykorzystaniem komórek regenerujących
Karataeva et al. THE MONITORING ORGANIZATION OF THE INDIVIDUAL REHABILITATION PROGRAMS IMPLEMENTATION EFFECTIVENESS IN NIZHNY NOVGOROD REGION
Tuman Sinus bradycardia: case report